Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E-islet 01 in Type 1 Diabetes with Impaired Hypoglycemic Awareness
NCT07126873Phase 2Recruiting
- Sponsor
- EndoCell Therapeutics
- Start
- Aug 2025
- Primary completion
- Dec 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of E-islet 01 in type 1 diabetes mellitus (T1D), sponsored by EndoCell Therapeutics. Started Aug 2025; status: recruiting.
02
Drugs
E-islet 01
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT07126873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07126873.